|

CAR-T Cell Therapy Clinical Trials

7 actively recruiting trials across 2 locations

▼ -1 trial since July 2026

Also known as: Axicabtagene ciloleucel, Chimeric Antigen Receptor T-cell, Chimeric antigen receptor T-Cell Therapy, Lisocabtagene maraleucel .

Pipeline

Phase 1: 3Phase 2: 3

Top Sponsors

  • Washington University School of Medicine1
  • University Hospital, Lille1
  • The First Affiliated Hospital of Soochow University1
  • National University Hospital, Singapore1
  • Lazaros Lekakis1

Indications

  • Cancer7
  • CAR T-Cell-Related Encephalopathy Syndrome1
  • Lymphoblastic Leukemia, Acute, Childhood1
  • Aggressive Non-Hodgkin Lymphoma1
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative1

Other5 trials

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
Phase 1
Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
Phase 2
Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy
Phase 2
Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19
Phase 1
Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment

Miami, Florida1 trial

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

University of Miami

Phase 2

St Louis, Missouri1 trial

NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma

Washington University School of Medicine

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.